![](/img/cover-not-exists.png)
2134 POSTER Clinical benefit of trastuzumab plus vinorelbine as second-line treatment for women with HER2-positive metastatic breast cancer beyond disease progression
P. Chollet, X. Durando, L. Mauriac, C. Delcambre, P. Maillart, C. Veyret, M.A. Mouret-Reynier, I. van Praagh, T. BachelotVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70896-0
File:
PDF, 64 KB
english, 2007